COVID-19: CSIR DG supports ICMR over WHO's decision on HCQ clinical trials

Video credit: ANI
Published on May 27, 2020 - Duration: 01:43s

COVID-19: CSIR DG supports ICMR over WHO's decision on HCQ clinical trials

While commenting on World Health Organisation's decision to temporarily suspend clinical trials of hydroxychloroquine, Director General of Council of Scientific and Industrial Research (CSIR), Shekhar Mande supported ICMR's judgement on HCQ trials.

"I'm sure WHO will take consider the call in coming time.

We should trust ICMR's judgement, they are well qualified.

Hence, we should continue," said Shekhar Mande while talking to ANI.

Advertisement

You are here

Related videos from verified sources

Scientists Want To Repurpose Polio Vaccine To Battle COVID-19 00:38
Video credit: Wochit - Published 3 weeks ago 

‘Not ayurvedic’: CSIR on plant-based drug ACQH to be tested for Covid treatment 01:59
Video credit: HT Digital Content - Published on June 6, 2020 

'WHO should've researched independently’: CSIR welcomes HCQ trial resumption 01:41
Video credit: HT Digital Content - Published on June 4, 2020